-
Mashup Score: 0Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM - 6 month(s) ago
Original Article from The New England Journal of Medicine — Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Source: www.nejm.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM - 6 month(s) ago
Original Article from The New England Journal of Medicine — Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Source: www.nejm.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM - 6 month(s) ago
Original Article from The New England Journal of Medicine — Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Source: www.nejm.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM - 6 month(s) ago
Original Article from The New England Journal of Medicine — Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Source: www.nejm.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM - 6 month(s) ago
Original Article from The New England Journal of Medicine — Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Source: www.nejm.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM - 6 month(s) ago
Original Article from The New England Journal of Medicine — Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Source: www.nejm.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM - 6 month(s) ago
Original Article from The New England Journal of Medicine — Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Source: www.nejm.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM - 7 month(s) ago
Original Article from The New England Journal of Medicine — Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Source: www.nejm.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors - 1 year(s) ago
Advances in hematopoietic cell transplantation (HCT) practices over the past 2 decades, particularly the introduction of reduced-intensity conditioning regimens and the improvement in palliative/supportive care services, have resulted in HCT becoming better tolerated in older patients (≥60 years) who were previously excluded from consideration for transplantation. Consequently, the upper age…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ASTCTChat Q7: Does the clinical trial enrollment of this population skew these data towards higher QoL than the general older transplant population?https://t.co/kgBOAbvffh https://t.co/3eKroUK34f
-
-
Mashup Score: 0Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors - 1 year(s) ago
Advances in hematopoietic cell transplantation (HCT) practices over the past 2 decades, particularly the introduction of reduced-intensity conditioning regimens and the improvement in palliative/supportive care services, have resulted in HCT becoming better tolerated in older patients (≥60 years) who were previously excluded from consideration for transplantation. Consequently, the upper age…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
Q5: What are your toxicity concerns and pearls which other centers should keep in mind? #ASTCTChat https://t.co/kYrcCuzYzW https://t.co/p4Jf1fCnoO